Gene Editing Technologies Market to Grow with CAGR of 10.25% through 2029
Rising awareness of genomics tools is expected to drive the
growth of Global Gene Editing Technologies Market during the forecast period
2025-2029
According to TechSci Research report, “Gene Editing Technologies Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029”, the Global
Gene Editing Technologies Market stood at USD 5.24 billion in 2023 and is
anticipated to grow with a CAGR of 10.25% in the forecast period, 2025-2029. The
Gene Editing Technologies market has undergone remarkable growth in recent
years, driven by the escalating demand for advanced tools that facilitate the
manipulation and modification of genetic material. This dynamic market is
characterized by the continuous development and commercialization of innovative
technologies, offering the ability to make precise and targeted modifications
within the DNA of living organisms. A standout in this landscape is the
revolutionary CRISPR-Cas9 gene-editing tool, which has surged ahead, providing
unparalleled accuracy and efficiency in genetic manipulation. The
transformative capabilities of CRISPR-Cas9 have opened up new frontiers across
various sectors, particularly in medicine, agriculture, and biotechnology. In
the medical domain, gene editing technologies present immense promise for
addressing genetic disorders. Researchers and pharmaceutical companies are
actively exploring these technologies' therapeutic potential to correct or
eliminate disease-causing mutations, resulting in the development of novel
therapies for conditions that were once deemed incurable. Simultaneously, gene
editing is gaining significant traction in agriculture, where it holds the
potential to revolutionize crop yield, enhance nutritional content, and confer
resilience to environmental stressors in plants. However, the gene editing
technologies market is not without its challenges and ethical considerations.
Concerns about the potential misuse of these powerful tools and the possibility
of unintended consequences have triggered ongoing discussions around
responsible and ethical usage. Regulatory frameworks are evolving to address
these concerns, ensuring that gene editing technologies are applied safely and
ethically. As the market continues to expand, collaborative efforts between
research institutions, biotechnology companies, and academic organizations are
becoming increasingly prevalent. These strategic partnerships are geared
towards expediting the development of novel gene-editing technologies and
translating them into practical applications. With continuous advancements and
an expanding understanding of genetic mechanisms, the gene editing technologies
market is poised for further growth, promising transformative impacts across
diverse industries. The trajectory indicates a future where precision genetic
modifications become increasingly accessible and influential in reshaping
various facets of our world.
Browse over XX Market data Figures spread
through XX Pages and an in-depth TOC on "Global Gene Editing Technologies Market”
Global Gene Editing Technologies Market is segmented
into offerings, technology, application, end user, regional distribution, and company.
Based on offerings, the Market is divided into gene editing products, gene
editing services. Gene editing services dominated the Market in 2023.This is attributable
due to several factors. Gene editing technologies are complex,
requiring specialized expertise and infrastructure, making outsourcing to
service providers an attractive option for companies and researchers. The rapid
pace of advancements in gene editing techniques necessitates access to
cutting-edge technologies, which gene editing service providers can readily
offer. Additionally, outsourcing enables cost-effectiveness, as establishing
and maintaining in-house capabilities can be financially burdensome. The gene
editing services segment also provides flexibility, allowing clients to tailor
projects to their specific needs. This strategic outsourcing model ensures
efficient utilization of resources and expertise, thereby driving the
prominence of the gene editing services segment in the dynamic and evolving
gene editing technologies market.
Based on end user, the Market is divided into academic
institutes and research centers, life sciences companies, contract research
organizations (CROS)/ contract manufacturing organizations (CMOS). Life
sciences companies dominated the Market in 2023.This is attributable due to their
pivotal role in advancing research, development, and commercialization. Life
sciences firms possess the expertise, infrastructure, and financial resources
necessary to drive innovation in gene editing. Their robust R&D capabilities
facilitate the creation of cutting-edge technologies, like CRISPR-Cas9,
fostering breakthroughs in precision genetic manipulation. Moreover, these
companies often establish strategic collaborations, leveraging their collective
knowledge to accelerate advancements. The imperative to address unmet medical
needs and the potential for lucrative opportunities in therapeutic applications
reinforce life sciences companies' prominence. Their ability to navigate
complex regulatory landscapes further positions them at the forefront of the
gene editing technologies market, shaping the industry's trajectory.
Based on region, the Global Gene Editing Technologies
Market is divided into North America, Europe, Asia Pacific, South America,
Middle East & Africa. North America dominated the Market in 2023. This is
due a convergence of factors. The region boasts a robust biotechnology and
pharmaceutical industry, housing key players and research institutions.
Additionally, North America has a substantial investment ecosystem, attracting
significant funding for gene editing research and development. The presence of
a well-established healthcare infrastructure, coupled with a favorable
regulatory environment, accelerates the translation of innovations into
practical applications. Collaborations between academia and industry further
fuel advancements. The high prevalence of genetic disorders and a proactive
approach toward adopting cutting-edge therapies contribute to the region's
dominance, positioning North America at the forefront of the global Gene
Editing Technologies market.
Major companies operating in Global Gene Editing
Technologies Market are:
- Addgene Inc.
- BRAIN Biotech AG
- Cellectis S.A.
- Creative Biolabs, Inc.
- CRISPR Therapeutics
AG
- BioRad Laboratories
Inc.
- DNA Script SAS
- GeneCopoeia, Inc.
- Merck KGaA
- PerkinElmer Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The global Gene Editing Technologies market is
propelled by increasing demand for advanced tools in genetic manipulation, with
CRISPR-Cas9 leading the way. Its unparalleled precision in DNA modification has
revolutionized medicine, agriculture, and biotechnology. In the medical sector,
it holds promise for treating genetic disorders. The surge in collaborations
between research institutions and biotech companies accelerates technology
development. Ethical considerations and evolving regulatory frameworks address
potential misuse. As partnerships expand, the market is poised for
transformative growth, driven by continuous advancements and applications
across diverse industries” said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based management consulting firm.
“Gene Editing Technologies Market - Global Industry
Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Offerings (Gene Editing Products, Gene Editing Services), By
Technology (CRISPR Gene Editing Technology, Non-CRISPR Gene Editing Technology
(Zinc-Finger Nucleases (ZFNs), TAL Effector Nucleases (TALENs), Meganucleases),
By Application (Agricultural, Biomedical (Drug Discovery, Gene Therapy,
Diagnostics)), By End User (Academic Institutes and Research Centers, Life
Sciences Companies, Contract Research Organizations (CROs)/ Contract
Manufacturing Organizations (CMOs)), By Region and Competition, 2019-2029F”, has evaluated
the future growth potential of Global Gene Editing Technologies Market and provides statistics & information on Market
size, structure and future Market growth. The report intends to provide
cutting-edge Market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Gene
Editing Technologies Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com